Diabetes

Charlotte RobinsonChronic Kidney Disease | August 12, 2025
Real-world data provided strong evidence supporting GLP-1 RA use in patients with diabetes receiving dialysis.
Read More
Freely FilteredNephrology Times | August 13, 2025
This Freely Filtered episode discusses metformin termination as explored by target trial emulation.
Lauren Dembeck, PhDType 2 Diabetes | June 25, 2025
Lifestyle and metformin interventions cut diabetes risk for 21 years in adults with prediabetes, DPP study shows.
Victoria SochaType 2 Diabetes | June 20, 2025
Tirzepatide linked to reduced muscle fat infiltration and volume in type 2 diabetes, per SURPASS-3 MRI substudy findings.
Charlotte RobinsonHyperkalemia | June 20, 2025
Use of SGLT2i with RAASi is associated with reduced risk for hyperkalemia in the clinical setting, a study found.
Victoria SochaDiabetes | June 17, 2025
Chronic hyperglycemia in pediatric type 1 diabetes may impair white matter development; brain changes persist into puberty.
Charlotte RobinsonChronic Kidney Disease | June 26, 2025
An observational study shed light on how family medical history may affect chronic kidney disease (CKD) outcomes.
Charlotte RobinsonDiabetes and Hypertension | June 23, 2025
The accuracy of continuous glucose monitoring versus self-monitored blood glucose in hemodialysis patients is not well known.
Charlotte RobinsonHyperkalemia | June 13, 2025
Researchers assessed the landscape of QSP modeling and developed a use case for QSP to determine hyperkalemia risk.
Charlotte RobinsonNKF Spring Clinical Meetings 2024 | June 23, 2025
Two years after its approval, researchers studied the use of finerenone in adults with type 2 diabetes and CKD.
Charlotte RobinsonDiabetes and Hypertension | March 29, 2024
Medicare Part D spending on GLP-1 drugs has soared to $5.7 billion, straining Medicare spending.
Charlotte RobinsonDiabetes and Hypertension | March 29, 2024
Current practice guidelines do not address dietary management specific to diabetic kidney disease (DKD).
Charlotte RobinsonDiabetes and Hypertension | March 8, 2024
AstraZeneca has removed tozorakimab from its phase 2 pipeline for diabetic kidney disease.
Patrick DalyAtrial Fibrillation | July 10, 2025
Researchers, led by Yehuda Handelsman, conducted a post-hoc analysis of the ATHENA and EURIDIS/ADONIS studies and ...
Patrick DalyAtherosclerotic Disease | July 10, 2025
According to Silvia Giovannini and colleagues from the Università Cattolica del Sacro Cuore in Rome, Italy, recent ...
DocWire News EditorsAtrial Fibrillation | July 10, 2025
Diabetes mellitus (DM) is a common comorbidity in patients with atrial fibrillation (AF) and is associated with an ...
DocWire News EditorsAAOS 2021 | February 5, 2024
Patient frailty is associated with higher prevalence of certain hospital-acquired conditions (HACs) in patients ...
DocWire News EditorsAtherosclerotic Disease | July 10, 2025
A new high-sensitivity cardiac troponin helps predict adverse cardiovascular events in diabetic patients with critical ...
Rob DillardAtherosclerotic Disease | July 10, 2025
Patients with diabetes have a much higher risk of complications following coronary artery bypass surgery compared with ...
Kaitlyn D’OnofrioDiabetes | April 11, 2023
As vascular-related deaths have declined among patients with diabetes, they are no longer the leading cause of death in ...
Latest News
August 13, 2025